TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2704503

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + norethisterone acetate 1 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + megestrol acetate 5 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + norethisterone acetate 0.5 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2 mg 17 beta‐estradiol + megestrol acetate 2.5 mg
Number of subjects: 60
Study: 647254

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 178

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 178
Study: 31894578

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL)
Number of subjects: 2020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2020
Study: 30382743

Group type: EXPERIMENTAL
Intervention: PREVAIL peer support intervention (n = 34)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: PREVAIL peer support intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care (n = 36)
Number of subjects: 70
Study: 28452716

Group type: EXPERIMENTAL
Intervention: CK-MB levels during BPPV attack
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: CK-MB levels before BPPV attack
Number of subjects: 35

Group type: COMPARATOR
Intervention: CK-MB levels in control group
Number of subjects: 35
Study: 25794941

Group type: EXPERIMENTAL
Intervention: Atraumatic needle (Sprotte [S])
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traumatic needle (Quincke [Q])
Number of subjects: 100
Study: 23258626

Group type: EXPERIMENTAL
Intervention: Testosterone patch for 36 months
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo patch for 36 months
Number of subjects: 67
Study: 21335677

Group type: EXPERIMENTAL
Intervention: Lycra arm splint wear combined with goal directed training
Number of subjects: 16
Study: 19549428

Group type: EXPERIMENTAL
Intervention: Loratadine/montelukast (L/M; 10 mg/10 mg)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 17258304

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs) for 48 months or more
Number of subjects: 667

Group type: COMPARATOR
Intervention: Nonusers of inhaled corticosteroids (ICSs)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs) for 4 years or more in subjects with high total IgE (>100 kU/L)
Number of subjects: 667

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICSs) in subjects with lower total IgE
Number of subjects: 667
Study: 15606733

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream applied 5 times/week for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream applied 5 times/week for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reflectance-mode confocal microscopy
Number of subjects: 0
Study: 11346249

Group type: EXPERIMENTAL
Intervention: Acute myocardial infarction (AMI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Unstable angina pectoris (USAP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 40
Study: 9554045

Group type: EXPERIMENTAL
Intervention: Preconditioning
Number of subjects: 36
Study: 8059725

Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 468

Group type: COMPARATOR
Intervention: Surgical therapy
Number of subjects: 468
Study: 2648286

Group type: EXPERIMENTAL
Intervention: Metaproterenol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combined metaproterenol and atropine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29982765

Group type: EXPERIMENTAL
Intervention: Strengths-based behavioral intervention
Number of subjects: 64
Study: 28526477

Group type: EXPERIMENTAL
Intervention: recipe card plus video modelling
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: recipe card plus video prompting
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: recipe card plus video elements
Number of subjects: 141

Group type: COMPARATOR
Intervention: recipe card only
Number of subjects: 141
Study: 25903358

Group type: EXPERIMENTAL
Intervention: C-MAC videolaryngoscope
Number of subjects: 0
Study: 23712737

Group type: EXPERIMENTAL
Intervention: levamisole (5 mg/rat/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: levamisole
Number of subjects: 22
Study: 22117578

Group type: EXPERIMENTAL
Intervention: Educational self-management program for CHF (6 months duration, 6 nurse-directed sessions once per month)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard medical treatment and care (Control group)
Number of subjects: 102
Study: 19326108

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO(3), n = 8), 500 mg bid
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CaCO(3)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 17728427

Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 mg, 15 mg, 20 mg, or 30 mg)
Number of subjects: 12
Study: 15054430

Group type: EXPERIMENTAL
Intervention: Two portions (300 g) of fruits and vegetables daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Five portions (750 g) of fruits and vegetables daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: High intake (five portions)
Number of subjects: 40
Study: 12449467

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different radiotherapy modalities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different types of surgery
Number of subjects: 0
Study: 9695991

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholate (UDC) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 0
Study: 8016587

Group type: EXPERIMENTAL
Intervention: Low energy laser (LEL) treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 22
Study: 2699615

Group type: EXPERIMENTAL
Intervention: Curcuma domestica Val.
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Flatulence treatment
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: All groups (Curcuma domestica Val., Flatulence, Placebo)
Number of subjects: 116
Study: 769971

Group type: EXPERIMENTAL
Intervention: DTIC (NSC-45388)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DTIC (NSC-45388) with other drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DTIC (NSC-45388) as an adjuvant to standard surgical therapy
Number of subjects: 0
Study: 30728950

Group type: EXPERIMENTAL
Intervention: Full version of Smoke Free app
Number of subjects: 28112

Group type: COMPARATOR
Intervention: Reduced version of Smoke Free app
Number of subjects: 28112
Study: 26972526

Group type: EXPERIMENTAL
Intervention: Movement imitation therapy (experimental group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no imitation training)
Number of subjects: 16
Study: 24331278

Group type: EXPERIMENTAL
Intervention: Parental training
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Family feedback
Number of subjects: 217

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 217
Study: 23039993

Group type: EXPERIMENTAL
Intervention: Single umbilical incision laparoscopic surgery (SILS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (CL)
Number of subjects: 50
Study: 20413299

Group type: EXPERIMENTAL
Intervention: Cetuximab treatment in KRAS wild type patients
Number of subjects: 559

Group type: COMPARATOR
Intervention: No cetuximab treatment in KRAS wild type patients (control group)
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Other markers (PIK3CA mutation, loss of PTEN expression, EGFR GCN, HER2 GCN)
Number of subjects: 559
Study: 17905952

Group type: EXPERIMENTAL
Intervention: Minimal debridement technique
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional clearance technique
Number of subjects: 49
Study: 16135348

Group type: EXPERIMENTAL
Intervention: 0.0625% bupivacaine plus fentanyl (BF) 3 microg/mL
Number of subjects: 70

Group type: COMPARATOR
Intervention: 0.15% ropivacaine (R)
Number of subjects: 70
Study: 12239234

Group type: EXPERIMENTAL
Intervention: Omapatrilat (40 or 80 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fosinopril (20 mg)
Number of subjects: 24
Study: 10065895

Group type: EXPERIMENTAL
Intervention: Heparin (50 IU/kg)
Number of subjects: 23
Study: 7733424

Group type: EXPERIMENTAL
Intervention: Special intervention (2 hours of behaviorally based education on dietary changes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual intervention (5 minutes of counseling)
Number of subjects: 40
Study: 2126738

Group type: EXPERIMENTAL
Intervention: Leuprolide + Flutamide (L + F)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Leuprolide (L) alone
Number of subjects: 617
Study: 7021263

Group type: EXPERIMENTAL
Intervention: Amoxycillin administered twice daily (50 mg/kg body-weight/day)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Amoxycillin administered four times daily (50 mg/kg body-weight/day)
Number of subjects: 34
Study: 31398066

Group type: COMPARATOR
Intervention: Facemask therapy (FM group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Facemask therapy with a miniscrew (FM+MS group)
Number of subjects: 40
Study: 31101920

Group type: EXPERIMENTAL
Intervention: Physical activity behavioral change intervention delivered by physical therapists in 18 sessions over 12 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual activity
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Physical activity behavioral change intervention
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: RCT participants (n = 60)
Number of subjects: 120
Study: 27885746

Group type: EXPERIMENTAL
Intervention: Enhanced couple-focused group (ECG) intervention
Number of subjects: 302

Group type: COMPARATOR
Intervention: Couples' support group
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Both interventions (ECG and support group)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: ECG intervention
Number of subjects: 302

Group type: COMPARATOR
Intervention: Support group
Number of subjects: 302
Study: 26068921

Group type: EXPERIMENTAL
Intervention: paper-based Map Me
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: web-based Map Me
Number of subjects: 0

Group type: COMPARATOR
Intervention: no information (control)
Number of subjects: 0
Study: 24521647

Group type: EXPERIMENTAL
Intervention: Biapenem (300 mg every 12 h)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Meropenem (500 mg every 8 h)
Number of subjects: 272
Study: 21988649

Group type: EXPERIMENTAL
Intervention: Accumulated running (ten 3-min bouts with 30 min rest between bouts)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Continuous running (one 30-min bout)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (resting)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Accumulated running and Continuous running
Number of subjects: 10
Study: 19300186

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional patient care (Control)
Number of subjects: 0
Study: 17542199

Group type: EXPERIMENTAL
Intervention: Colgate Total Toothpaste
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 14766425

Group type: EXPERIMENTAL
Intervention: Vesical pacing with parameters: amplitude of 5 mA, pulse width of 200 ms, frequency 20% higher than basal vesical waves
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no pacing)
Number of subjects: 36
Study: 11743708

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (active treatment)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Traditional symptom alleviation (passive treatment)
Number of subjects: 29
Study: 9924711

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg orally once daily for 3 days (n = 150)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Co-amoxiclav 625 mg orally three times daily for 5-10 days (n = 153)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 303
Study: 9419764

Group type: EXPERIMENTAL
Intervention: Estrogen alone (0.625 mg conjugated equine estrogen for 6 months)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Estrogen with progestin (0.625 mg conjugated equine estrogen with 10 mg medroxyprogesterone acetate for 10 days each month for 6 months)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Insulin tolerance test (ITT) and frequently sampled intravenous glucose tolerance test (FSIVGTT)
Number of subjects: 28
Study: 2954477

Group type: EXPERIMENTAL
Intervention: Transluminal angioplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical revision
Number of subjects: 0
Study: 31509319

Group type: EXPERIMENTAL
Intervention: Fish skin grafts
Number of subjects: 170

Group type: COMPARATOR
Intervention: dHACM
Number of subjects: 170
Study: 29661378

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside 0.5 μg kg-1 min-1 during RS-ketamine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo during RS-ketamine infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside 0.5 μg kg-1 min-1 during esketamine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo during esketamine infusion
Number of subjects: 0
Study: 28814317

Group type: EXPERIMENTAL
Intervention: Collabri model for collaborative care
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 1092
Study: 26223033

Group type: EXPERIMENTAL
Intervention: Individualized feedback during laparoscopic simulator training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 16
Study: 23356580

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 26
Study: 16643394

Group type: EXPERIMENTAL
Intervention: CRT-D devices
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: DER testing
Number of subjects: 501
Study: 14653298

Group type: EXPERIMENTAL
Intervention: Nupro coarse prophy paste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nupro medium prophy paste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nupro fine prophy paste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clinpro prophy paste
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simulated toothbrushing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline and disk treatment
Number of subjects: 20
Study: 10523001

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant human GH treatment (0.15 IU/kg x day) for 1 week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GH withdrawal
Number of subjects: 0
Study: 8619701

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (600 mg in divided doses 12 hours before operation)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1743354

Group type: EXPERIMENTAL
Intervention: Pilocarpine pretreatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: No pretreatment (Control)
Number of subjects: 50
Study: 7041955

Group type: EXPERIMENTAL
Intervention: Meptazinol
Number of subjects: 358

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 358
Study: 31753674

Group type: EXPERIMENTAL
Intervention: LAIV4
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: IIV3
Number of subjects: 130
Study: 31264494

Group type: EXPERIMENTAL
Intervention: Home monitoring with a rapid fecal calprotectin test and symptom questionnaire every second month and in cases with increasing symptoms.
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group filled in symptom questionnaire at baseline, 6 months, and 12 months, and for outpatient clinic appointments.
Number of subjects: 180
Study: 26988800

Group type: EXPERIMENTAL
Intervention: Web-based tailored intervention (Kanker Nazorg Wijzer)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 462
Study: 26031572

Group type: EXPERIMENTAL
Intervention: Self-collection of high-risk human papillomavirus (HR-HPV) testing
Number of subjects: 500

Group type: COMPARATOR
Intervention: Visual inspection with acetic acid (VIA)
Number of subjects: 500
Study: 23865647

Group type: EXPERIMENTAL
Intervention: Health promotion intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Financial literacy control intervention
Number of subjects: 200
Study: 21572316

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique (group US)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional surface landmark‐guided technique (group LM)
Number of subjects: 120
Study: 18521599

Group type: EXPERIMENTAL
Intervention: Posterior lumbar interbody fusion (PLIF)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Posterolateral fusion (PLF)
Number of subjects: 138
Study: 16829774

Group type: EXPERIMENTAL
Intervention: Smoking cessation interventions for women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking cessation interventions for smokers with psychiatric diagnoses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking cessation interventions for smokers addicted to illicit drugs, alcohol, or both
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking cessation interventions for African Americans
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking cessation interventions for older adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking cessation interventions for gay, lesbian, bisexual, and transgender smokers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking cessation interventions for American Indians and Alaska Natives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking cessation interventions for Hispanics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking cessation interventions for Asian Americans
Number of subjects: 0
Study: 15210658

Group type: EXPERIMENTAL
Intervention: Minimal enteral feeding (MEF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No enteral feeding (NEF)
Number of subjects: 42
Study: 11308434

Group type: EXPERIMENTAL
Intervention: St John's wort extract (900 mg/d for 4 weeks, increased to 1200 mg/d if no adequate response)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: St John's wort extract
Number of subjects: 200

Group type: COMPARATOR
Intervention: St John's wort extract and Placebo
Number of subjects: 200
Study: 9257200

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg i.v. for dose 1, placebo for dose 2, ketorolac 30 mg i.v. for doses 3, 4, and 5 (Group 2)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg i.v. for dose 1, ketorolac 30 mg i.v. for doses 3, 4, and 5 (Group 1)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo for all doses (Group 3)
Number of subjects: 248
Study: 8305166

Group type: EXPERIMENTAL
Intervention: 20 mg nitrendipine once daily for 12 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5 mg cilazapril once daily for 12 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 20
Study: 3324616

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional analgesia (CA)
Number of subjects: 36
Study: 28681263

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (n = 143)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Normal weight control group
Number of subjects: 195
Study: 26950708

Group type: COMPARATOR
Intervention: Auscultation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound
Number of subjects: 42
Study: 25329848

Group type: EXPERIMENTAL
Intervention: Low-fidelity rubberized line
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-fidelity ethylene-vinyl acetate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-fidelity chicken leg skin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-fidelity pig foot skin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group 1 (didactic materials)
Number of subjects: 60
Study: 22459388

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100,000 units of oral vitamin D3)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 75
Study: 19912184

Group type: EXPERIMENTAL
Intervention: UM-trained (50 interns)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (50 interns)
Number of subjects: 100

Group type: COMPARATOR
Intervention: UMCG trainees
Number of subjects: 100
Study: 18713490

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing containing hyaluronic acid (HC + HA)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Reference hydrocolloid dressing not containing hyaluronic acid (HC)
Number of subjects: 125
Study: 16629920

Group type: EXPERIMENTAL
Intervention: Scenario-based simulation training
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (traditional techniques)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 99
Study: 12747455

Group type: EXPERIMENTAL
Intervention: Mastic chewing gum
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 20
Study: 11321442

Group type: EXPERIMENTAL
Intervention: Lumbrokinase
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 8997575

Group type: EXPERIMENTAL
Intervention: Maxitrol (neomycin sulphate 3500 IU/mL, polymyxin‐B sulphate 6000 IU/mL with dexamethasone 0.1%)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Maxidex (dexamethasone 0.1% alone)
Number of subjects: 111
Study: 1617932

Group type: EXPERIMENTAL
Intervention: roxithromycin 150 mg twice daily
Number of subjects: 250

Group type: COMPARATOR
Intervention: cefaclor 250 mg three times daily
Number of subjects: 250
Study: 6391390

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120